ArticleBriefings in bioinformatics2026
Computational framework for therapeutic target discovery via perturbation simulation: application to cystic fibrosis airway disease.
Article in Briefings in bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computational methods for therapeutic target discovery face challenges in integrating multi-scale biological data and predicting system-wide therapeutic effects. We present a computational framework that integrates single-cell transcriptomics, weighted gene co-expression network analysis (WGCNA), and computational perturbation simulation to systematically discover novel therapeutic targets. The framework constructs a knowledge graph comprising 29 896 nodes (23 530 genes and 6366 pathways) with 322 136 edges, integrating gene-gene, gene-pathway, and module relationships. Using perturbation simulation algorithms, we systematically explored 265 candidate targets, scoring each based on perturbation magnitude, module response, therapeutic effect, and statistical significance. Applied to single-cell RNA sequencing data from 38 patients (51 415 cells), the framework identified 66 novel therapeutic targets, including nine very high novelty targets. Computational validation demonstrates efficient scalability (knowledge graph construction: <5 min; 265 perturbation simulations: <2 min) and robust performance across different module sizes. This approach represents a novel computational method for systems-level therapeutic target discovery, with generalizable applications to other complex diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.